Evidence map›Paper›PMID 15569962›Full record

ArticleAmerican journal of public health2004

Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system?

LeChauncy D Woodard, Nancy R Kressin, Laura A Petersen

Abstract read
In one paragraph

Article in American journal of public health, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans.Journal of the American Heart Association · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

LeChauncy D WoodardHouston Center for Quality of Care and Utilization Studies, Michael E. DeBakey Veterans Affairs Medical Center, USA. lwoodard@bcm.tmc.edu
Nancy R Kressin
Laura A Petersen
Michael E. DeBakey VA Medical Center · US

Funding

BHP HRSA HHS 1 T32 PE 10031-01
6 · The paper itself

Abstract

objectivesWe examined whether racial differences exist in cholesterol monitoring, use of lipid-lowering agents, and achievement of guideline-recommended low-density lipoprotein (LDL) levels for secondary prevention of coronary heart disease.

methodsWe reviewed charts for 1045 African American and White patients with coronary heart disease at 5 Veterans Affairs (VA) hospitals.

resultsLipid levels were obtained in 67.0% of patients. Whites and African Americans had similar screening rates and mean lipid levels. Among the 544 ideal candidates for therapy, rates of treatment and achievement of target LDL levels were similar.

conclusionsWe found no disparities in cholesterol management. This absence of disparities may be the result of VA quality improvement initiatives or prescription coverage through the VA health care system.

Indexed as

Black or African AmericanCholesterol, LDLCoronary DiseaseDrug UtilizationHospitals, VeteransHumansHypercholesterolemiaHypolipidemic AgentsMaleMiddle AgedRisk FactorsWhite PeopleCholesterol, LDLHypolipidemic Agents

Identifiers

PMID15569962
PMCPMC1448600
OpenAlexW2104942328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.